Whalegun
Home

Samuel Kintz, President and CEO: Enliven Therapeutics ELVN Planned sale · Filed 25/05/01

Trade details

Type
Planned sale notice
Stock
Enliven Therapeutics ELVN
Person
Samuel KintzPresident and CEO
Planned sale date
25/05/01
Filed
25/05/01

More to sell after $1.2M in 3 months

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 25/04/01~25/05/31

Samuel Kintz's recent trades

  • Samuel Kintz

    Planned sale10b5-1 planEnliven Therapeutics

    $2M

    Filed 02/17

  • Samuel Kintz

    Planned sale10b5-1 planEnliven Therapeutics

    $1.7M

    Filed 01/09

  • Samuel Kintz

    Planned sale10b5-1 planEnliven Therapeutics

    $1.3M

    Filed 01/08

  • Samuel Kintz

    Planned sale10b5-1 planEnliven Therapeutics

    $84.6K

    Filed 25/12/17

  • Samuel Kintz

    Sell10b5-1 planEnliven Therapeutics

    $272.8K

    Filed 25/11/19